Načítá se...
A retrospective study to assess the risk of bladder cancer in type-2 diabetic patients treated with pioglitazone
INTRODUCTION: Pioglitazone has been a cornerstone of oral hypoglycemic therapy. Concerns have been raised about its association with urinary bladder cancer. Considering the wide usage of this drug, concrete and multiple population-based studies are needed to establish the safety of this drug. The pr...
Uloženo v:
| Vydáno v: | Perspect Clin Res |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wolters Kluwer - Medknow
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8011523/ https://ncbi.nlm.nih.gov/pubmed/33816203 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/picr.PICR_192_18 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|